Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to patients, the result of an audacious strategy offering a new way to develop medicine for neglected populations. Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to patients, the result of an audacious strategy offering a new way to develop medicine for neglected populations. National Sydney Morning Herald – Latest News
A small team of Australian scientists won a rare drug approval – and upended the pharma system
